Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Regeneron Pharmaceuticals
Pharma
Regeneron to collect $270M in renewed US Ebola drug supply deal
Regeneron is re-upping a supply pact for its approved Ebola treatment Inmazeb to the U.S. government, in a deal worth some $270 million.
Fraiser Kansteiner
Oct 27, 2026 9:28am
Big Pharma's Big Brand: Regeneron
Sep 29, 2026 11:20am
Regeneron podcast turns science into immersive experience
Aug 20, 2026 7:35pm
Pasatru approved by FDA as 2nd drug for rare bone lesion disease
Aug 19, 2026 2:35pm
EyePoint phase 3 for AMD disappoints, tanking stock
Aug 17, 2026 3:30pm
A genomics library for the AI era
Aug 14, 2026 9:29am
